Ciprofloxacin prolonged-release tablets do not affect warfarin pharmacokinetics and pharmacodynamics.
about
Importance of multi-p450 inhibition in drug-drug interactions: evaluation of incidence, inhibition magnitude, and prediction from in vitro dataAdherence to guidelines for avoiding drug interactions associated with warfarin--a Nationwide Swedish Register StudyEffect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trialsEffect of single-dose rifampin on the pharmacokinetics of warfarin in healthy volunteers.Lack of a meaningful effect of anacetrapib on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.Drug and dietary interactions of warfarin and novel oral anticoagulants: an update.
P2860
Ciprofloxacin prolonged-release tablets do not affect warfarin pharmacokinetics and pharmacodynamics.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Ciprofloxacin prolonged-releas ...... kinetics and pharmacodynamics.
@en
Ciprofloxacin prolonged-releas ...... kinetics and pharmacodynamics.
@nl
type
label
Ciprofloxacin prolonged-releas ...... kinetics and pharmacodynamics.
@en
Ciprofloxacin prolonged-releas ...... kinetics and pharmacodynamics.
@nl
prefLabel
Ciprofloxacin prolonged-releas ...... kinetics and pharmacodynamics.
@en
Ciprofloxacin prolonged-releas ...... kinetics and pharmacodynamics.
@nl
P2093
P2860
P356
P1476
Ciprofloxacin prolonged-releas ...... kinetics and pharmacodynamics.
@en
P2093
Bret Berner
Carla Washington
Corinne Campanella
Nicola C Hughes
S Y Eddie Hou
P2860
P304
P356
10.1177/0091270007305504
P577
2007-08-27T00:00:00Z